Enhancing metastatic colorectal cancer prediction through advanced feature selection and machine learning techniques.
Journal:
International immunopharmacology
PMID:
39226823
Abstract
BACKGROUND AND AIMS: Colorectal cancer (CRC) is the third most prevalent cancer globally, posing a significant challenge due to its high rate of metastasis. Approximately 20% of patients with CRC present with distant metastases at diagnosis, and over 50% develop metastases within five years. Accurate prediction of metastasis is crucial for improving survival outcomes in patients with CRC.